Related Experiment Video
Updated: Jul 4, 2026
03:42
A Simplified Protocol for Protecting Palatal Soft Tissue Donor Sites Using an Oral Mucoadhesive Bandage
Published on: February 17, 2026
Collagen scaffolds implanted in the palatal mucosa
Richard G Jansen1, Anne M Kuijpers-Jagtman, Toin H van Kuppevelt
1Orthodontics and Oral Biology, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands.
The Journal of Craniofacial Surgery
|June 4, 2008
Summary
Cross-linked type I collagen scaffolds show mild, transient inflammation and good integration in rat palates. These biocompatible scaffolds show promise for reducing scar tissue and improving outcomes in cleft palate surgery.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Oral and Maxillofacial Surgery
Background:
- Scarring after cleft palate repair impairs midface and upper jaw growth.
- Scaffold implantation during surgery may mitigate these adverse effects.
- Limited data exists on oral cavity scaffold tissue responses.
Purpose of the Study:
- To evaluate tissue reactions to cross-linked type I collagen scaffolds.
- To assess scaffold biocompatibility after submucoperiosteal implantation in rat palates.
Main Methods:
- Type I collagen scaffolds were implanted in rat palates (n=25).
- Histologic and immunohistochemical analyses were performed at 1, 2, 4, 8, and 16 weeks.
- Evaluated parameters included cell density, giant cells, inflammation, angiogenesis, and myofibroblasts.
Main Results:
- Mild, transient inflammation observed, subsiding by 8 weeks.
- Myofibroblast presence limited to the first 2 weeks.
- Significant angiogenesis peaked at 4 weeks.
- Scaffolds integrated well with host tissue.
Conclusions:
- Cross-linked type I collagen scaffolds are biocompatible.
- They elicit a mild, transient inflammatory response.
- These scaffolds show potential for improving cleft palate surgery outcomes.
